Tenaya Therapeutics (TNYA) Insider Trading & Ownership $1.13 -0.03 (-2.59%) Closing price 04:00 PM EasternExtended Trading$1.14 +0.02 (+1.33%) As of 05:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tenaya Therapeutics (NASDAQ:TNYA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage48.65%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$25.00MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$46.87K Get TNYA Insider Trade Alerts Want to know when executives and insiders are buying or selling Tenaya Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TNYA Insider Buying and Selling by Quarter Tenaya Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/18/2025Faraz AliCEOSell14,533$1.25$18,166.25 8/18/2025Tomohiro HigaSVPSell2,962$1.25$3,702.50 8/18/2025Whittemore TingleyInsiderSell5,053$1.25$6,316.25 5/16/2025Faraz AliCEOSell3,189$0.44$1,403.16 5/16/2025Tomohiro HigaSVPSell1,390$0.44$611.60 5/16/2025Whittemore TingleyInsiderSell2,937$0.44$1,292.28 3/10/2025Faraz AliCEOSell9,741$0.54$5,260.14 3/10/2025Tomohiro HigaSVPSell2,482$0.54$1,340.28 3/10/2025Whittemore TingleyInsiderSell7,398$0.54$3,994.92 3/5/2025Group Gp Lp Column IIIMajor ShareholderBuy35,714,284$0.70$24,999,998.80 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/18/2024Chihiro SaitoSVPSell2,258$2.12$4,786.96 (Data available from 1/1/2013 forward) TNYA Insider Trading Activity - Frequently Asked Questions Who is on Tenaya Therapeutics' Insider Roster? The list of insiders at Tenaya Therapeutics includes Chihiro Saito, David V Goeddel, Deepak Srivastava, Eli Casdin, Faraz Ali, Group Gp Lp Column III, Timothy Hoey, Tomohiro Higa, and Whittemore Tingley. Learn more on insiders at TNYA. What percentage of Tenaya Therapeutics stock is owned by insiders? 48.65% of Tenaya Therapeutics stock is owned by insiders. Learn more on TNYA's insider holdings. Which Tenaya Therapeutics insiders have been buying company stock? The following insider purchased TNYA shares in the last 24 months: Group Gp Lp Column III ($34,999,997.80). How much insider buying is happening at Tenaya Therapeutics? Insiders have purchased a total of 37,936,506 TNYA shares in the last 24 months for a total of $34,999,997.80 bought. Which Tenaya Therapeutics insiders have been selling company stock? The following insiders have sold TNYA shares in the last 24 months: Chihiro Saito ($11,616.03), Faraz Ali ($90,259.15), Timothy Hoey ($116,464.30), Tomohiro Higa ($5,654.38), and Whittemore Tingley ($33,070.37). How much insider selling is happening at Tenaya Therapeutics? Insiders have sold a total of 99,633 Tenaya Therapeutics shares in the last 24 months for a total of $257,064.23 sold. Tenaya Therapeutics Key ExecutivesMr. Faraz Ali M.B.A. (Age 51)CEO & Director Compensation: $890.06kDr. Deepak Srivastava M.D. (Age 57)Scientific Founder, Chairman of Scientific Advisory Board & Director Compensation: $120.5kMs. Leone D. Patterson M.B.A. (Age 62)Chief Financial & Business Officer Compensation: $619.38kDr. Whittemore G. Tingley M.D. (Age 56)PH.D., Chief Medical Officer Compensation: $645.79kDr. Eric N. Olson Ph.D.Scientific Founder & Member of Scientific Advisory BoardDr. Bruce R. ConklinScientific FounderDr. Saptarsi Haldar M.D.Scientific FounderDr. Sheng Ding Ph.D.Scientific FounderDr. Benoit G. Bruneau Ph.D.Scientific FounderDr. Kee-Hong Kim Ph.D. (Age 58)Chief Technology Officer More Insider Trading Tools from MarketBeat Related Companies Kodiak Sciences Insider Trading Erasca Insider Trading Cullinan Therapeutics Insider Trading COMPASS Pathways Insider Trading Prothena Insider Trading Tectonic Therapeutic Insider Trading CryoPort Insider Trading Gossamer Bio Insider Trading Replimune Group Insider Trading Y-mAbs Therapeutics Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying This page (NASDAQ:TNYA) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersOne tiny company just cracked Google’s $19B problemGoogle, Microsoft, IBM… every major AI player will be forced to secure massive amounts of this material just t...True Market Insiders | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenaya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenaya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access